[PubMed] [Google Scholar] 143.Xiao J, Lv Y, Lin B, Tipoe GL, Youdim MB, Xing F, Liu Y
Semaglutides effects on pregnancy are not fully understood, and while it is generally safe for weight management, its use during early pregnancy is not recommended
Specifications Formulated as a 30mg lyophilized vial for enhanced laboratory stability and reconstitution accuracy
New biological entities are either in discovery and preclinical (three) or in Phase II (three), including HMI-115, a prolactin receptor monoclonal antibody and MT 2990, a monoclonal antibody targeting interleukin-33 to treat pain
Contributors: All of the authors contributed equally to the writing and editing of this manuscript, reviewed it critically for intellectual content, gave final approval of the version to be published and agreed to be accountable for all aspects of the work